Core Insights - Mirion Technologies' shares surged 18.2% following a strong earnings report, driven by growth in its nuclear energy-related business [1] Financial Performance - In Q3, Mirion reported a revenue increase of 7.9% to $223.1 million and a 50% rise in non-GAAP earnings per share to $0.12, both exceeding expectations [2] - The company anticipates 7% to 9% growth for the year, with approximately 1 percentage point attributed to recent acquisitions in the nuclear segment [3] - Adjusted EPS is projected at $0.50 at the midpoint, with adjusted free cash flow expected between $100 million and $115 million, with the lower end of guidance raised since the last quarter [3] Segment Analysis - The nuclear segment is the larger and faster-growing part of Mirion's business, achieving 9% growth last quarter to $144.6 million, making up nearly two-thirds of total revenue, while the medical segment grew only 5.9% [4] - A 21% increase in the nuclear safety segment order book was reported, driven by a significant order from a small modular reactor customer, although the medical order book declined [5] Market Trends - The nuclear energy sector has seen substantial growth, with Mirion's stock up 70.3% for 2025, currently trading at over 70 times this year's adjusted free cash flow estimates [7] - Despite strong results, the stock is considered expensive, with expectations of mid-single-digit organic growth this year [9]